Cargando…

Role of Integrin Alpha4 in Drug Resistance of Leukemia

Chemotherapeutic drug resistance in acute lymphoblastic leukemia (ALL) is a significant problem, resulting in poor responsiveness to first-line treatment or relapse after transient remission. Classical anti-leukemic drugs are non-specific cell cycle poisons; some more modern drugs target oncogenic p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shishido, Stephanie, Bönig, Halvard, Kim, Yong-Mi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033044/ https://www.ncbi.nlm.nih.gov/pubmed/24904821 http://dx.doi.org/10.3389/fonc.2014.00099

Ejemplares similares

Cadherins, Selectins, and Integrins in CAM-DR in Leukemia
por: Kim, Hye Na, et al.
Publicado: (2020)

Effects of CD49d-targeted antisense-oligonucleotide on α4 integrin expression and function of acute lymphoblastic leukemia cells: Results of in vitro and in vivo studies
por: Duchartre, Yann, et al.
Publicado: (2017)

Adaptive Immunity and Pathogenesis of Diabetes: Insights Provided by the α4–Integrin Deficient NOD Mouse
por: Oulghazi, Salim, et al.
Publicado: (2020)

Editorial: Microenvironment and therapy-resistance in leukemias
por: Friedmann, Rachel, et al.
Publicado: (2023)

Alpha2beta1 Integrin Polymorphism in Diffuse Astrocytoma Patients
por: Teixeira, Silvia A., et al.
Publicado: (2022)

Co-culture of primary human T cells with leukemia cells to measure regulatory T cell expansion
por: Külp, Marius, et al.
Publicado: (2022)

Impact of Charged Particle Exposure on Homologous DNA Double-Strand Break Repair in Human Blood-Derived Cells
por: Rall, Melanie, et al.
Publicado: (2015)

Integrin Alpha V in Urine: A Novel Noninvasive Marker for Prostate Cancer Detection
por: Zemskova, Marina Y., et al.
Publicado: (2021)

Integrin Alpha-2 as a Potential Prognostic and Predictive Biomarker for Patients With Lower-Grade Glioma
por: Lin, Li, et al.
Publicado: (2021)

The role of hypoxia-inducible factor-1 alpha in multidrug-resistant breast cancer
por: Yong, Liyun, et al.
Publicado: (2022)

Characterizing the Motility of Chemotherapeutics-Treated Acute Lymphoblastic Leukemia Cells by Time-Lapse Imaging
por: Liu, Hsiao-Chuan, et al.
Publicado: (2020)

Integrins and p53 pathways in glioblastoma resistance to temozolomide
por: Martin, Sophie, et al.
Publicado: (2012)

Drug Resistance Mechanisms of Acute Myeloid Leukemia Stem Cells
por: Niu, Jialan, et al.
Publicado: (2022)

Regulation of Integrin Subunit Alpha 2 by miR-135b-5p Modulates Chemoresistance in Gastric Cancer
por: Wang, Qi, et al.
Publicado: (2020)

Drug Resistance Biomarkers and Their Clinical Applications in Childhood Acute Lymphoblastic Leukemia
por: Aberuyi, Narges, et al.
Publicado: (2020)

Integrin-Mediated Adhesion and Chemoresistance of Acute Lymphoblastic Leukemia Cells Residing in the Bone Marrow or the Central Nervous System
por: Scharff, Bibi Fatima Syed Shah, et al.
Publicado: (2020)

Effects of the small-molecule inhibitor of integrin α4, TBC3486, on pre-B-ALL cells
por: Hsieh, Y T, et al.
Publicado: (2014)

Integrin VLA-5 and FAK are Good Targets to Improve Treatment Response in the Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
por: Hu, Zhongbo, et al.
Publicado: (2014)

Overcoming Glucocorticoid Resistance in Acute Lymphoblastic Leukemia: Repurposed Drugs Can Improve the Protocol
por: Olivas-Aguirre, Miguel, et al.
Publicado: (2021)

Integrin alpha L controls the homing of regulatory T cells during CNS autoimmunity in the absence of integrin alpha 4
por: Glatigny, Simon, et al.
Publicado: (2015)

Screening of Drug Repositioning Candidates for Castration Resistant Prostate Cancer
por: Kim, In-Wha, et al.
Publicado: (2019)

The alpha 4 integrin chain is a ligand for alpha 4 beta 7 and alpha 4 beta 1
Publicado: (1995)

Albumin Modifies Responses to Hematopoietic Stem Cell Mobilizing Agents in Mice
por: Danner, Eva, et al.
Publicado: (2019)

CD3/CD19 Depletion for T-cell Reduction of Allogeneic Transplants: Mostly Efficient, but not Robust
por: Wiercinska, Eliza, et al.
Publicado: (2021)

The Role of Circular RNAs in the Drug Resistance of Cancers
por: Liu, Xin-Yuan, et al.
Publicado: (2022)

The Role of Sphingolipids Metabolism in Cancer Drug Resistance
por: Bataller, Marina, et al.
Publicado: (2021)

Targeted Drug Discovery for Pediatric Leukemia
por: Napper, Andrew D., et al.
Publicado: (2013)

Trametinib: Could It Be a Promising Drug to Treat Atypical Chronic Myeloid Leukemia?
por: Elsayed, Marwa, et al.
Publicado: (2022)

Transcriptome Profiling of N7-Methylguanosine Modification of Messenger RNA in Drug-Resistant Acute Myeloid Leukemia
por: Zhang, Bing, et al.
Publicado: (2022)

Reduced Intracellular Drug Accumulation in Drug-Resistant Leukemia Cells is Not Only Solely Due to MDR-Mediated Efflux but also to Decreased Uptake
por: Pisco, Angela Oliveira, et al.
Publicado: (2014)

Tumor Targeting via Integrin Ligands
por: Marelli, Udaya Kiran, et al.
Publicado: (2013)

Role of STAT3 in Transformation and Drug Resistance in CML
por: Nair, Rajesh R., et al.
Publicado: (2012)

Role of Melanin Chemiexcitation in Melanoma Progression and Drug Resistance
por: Premi, Sanjay
Publicado: (2020)

The Role of Exosomal microRNA in Cancer Drug Resistance
por: Guo, Qiao-ru, et al.
Publicado: (2020)

Cytotoxic Capacity of IL-15-Stimulated Cytokine-Induced Killer Cells Against Human Acute Myeloid Leukemia and Rhabdomyosarcoma in Humanized Preclinical Mouse Models
por: Rettinger, Eva, et al.
Publicado: (2012)

Absence of the CXCR4 antagonist EPI-X4 from pharmaceutical human serum albumin preparations
por: Gilg, Andrea, et al.
Publicado: (2021)

Generation and Characterization of Erythroid Cells from Human Embryonic Stem Cells and Induced Pluripotent Stem Cells: An Overview
por: Chang, Kai-Hsin, et al.
Publicado: (2011)

Role of integrin-linked kinase in drug resistance of lung cancer
por: Jia, Zhiyang
Publicado: (2015)

Integrin-Mediated Tumorigenesis and Its Therapeutic Applications
por: Li, Qingling, et al.
Publicado: (2022)

The Role of Non-Coding RNAs in Breast Cancer Drug Resistance
por: Tian, Jin-hai, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mqmu8pgr585bbvb8c3thf7kngj